Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Clinterooon Jan 17, 2014 11:02am

98 Views

Post# 22103636

RE:RE:RE:Someone can post the link to listen webinar ?

Ya he specifically mentioned sunscreen with the Cousteau foundation. Strange though if they already have an agreement with another sunscreen maker.

Neil also mentioned a huge benefit of sunscreen is that it can go to market very quick. No substantial studies, FDA approvals, etc. so to market in under a year.

But anyway, I still think this is a ways off. I suspect our share price turns on Wanbang and Obagi... nothing else. At least for 2014.

Bullboard Posts

Major military / commercial drone supplier has theories over mysterious sightings